4//SEC Filing
Henderson Jeffrey William 4
Accession 0001415889-24-011685
CIK 0001159036other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 5:56 PM ET
Size
7.6 KB
Accession
0001415889-24-011685
Insider Transaction Report
Form 4
Henderson Jeffrey William
Director
Transactions
- Award
Option to Purchase Common Stock
2024-04-25+8,804→ 8,804 totalExercise: $38.46Exp: 2034-04-25→ Common Stock (8,804 underlying) - Award
Common Stock
2024-04-25+6,501→ 53,611 total
Footnotes (2)
- [F1]Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) April 25, 2025 and (ii) the date of the Issuer's next annual meeting of stockholders.
- [F2]Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) April 25, 2025 and (ii) the date of the Issuer's next annual meeting of stockholders.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001324015
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 5:56 PM ET
- Size
- 7.6 KB